OPTHERION
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment of early-stage age-related macular degeneration, dense deposit disease, atypical hemolytic uremic syndrome, and other chronic diseases involving the alternative complement cascade. The company was founded in 2005 and is based in New Haven, Connecticut.
OPTHERION
Industry:
Biotechnology Health Care Medical
Founded:
2005-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.optherion.com
Total Employee:
11+
Status:
Active
Contact:
2034920287
Total Funding:
42 M USD
Technology used in webpage:
Viewport Meta Font Awesome Amazon BootstrapCDN Amazon Virginia Region Apache 2.2 NameBright StatCounter OpenSSL 0.9.8 Mod_ssl 2.2.22
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Current Advisors List
Current Employees Featured
Founder
Investors List
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series A - Optherion
GE Healthcare
GE Healthcare investment in Series A - Optherion
Domain Associates
Domain Associates investment in Series A - Optherion
Quaker BioVentures
Quaker BioVentures investment in Series A - Optherion
Pappas Ventures
Pappas Ventures investment in Series A - Optherion
Official Site Inspections
http://www.optherion.com
- Host name: 104.21.86.219
- IP address: 104.21.86.219
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Optherion"
Optherion Company Profile 2024: Valuation, Investors, Acquisition ...
Information on acquisition, funding, cap tables, investors, and executives for Optherion. Use the PitchBook Platform to explore the full profile.See details»
Optherion - Funding, Financials, Valuation & Investors
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment ofSee details»
Optherion - VentureRadar
"Optherion is a biotechnology company that is developing diagnostic and disease-modifying products for the management and treatment of dry and wet Age-Related Macular …See details»
Optherion - Products, Competitors, Financials, Employees, …
Who are the investors of Optherion? Investors of Optherion include Johnson & Johnson Innovation, Domain Associates, Biogen Idec New Ventures, Pappas Ventures, Quaker …See details»
Optherion Inc. | Insights
Jul 1, 2009 Untangling the genetics of AMD The Maritime Center 11th Floor 555 Long Wharf Drive New Haven, CT 06511 Phone: (203) 781-0072 Web Site: www.optherion.com Contact: …See details»
Optherion - Contacts, Employees, Board Members, Advisors
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment ofSee details»
Optherion Inc. - BioCentury Company Profiles - BCIQ
May 26, 2016 Optherion Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Optherion Inc. - Scrip
Jul 1, 2009 Based on a growing understanding of the genetics of age-related macular degeneration and its association with the immune system, Optherion is developing a treatment …See details»
$37 Million Financing for Company Based on Macular …
Oct 9, 2007 Optherion, Inc. — a company that will use groundbreaking discoveries by scientists at Yale and the University of Iowa to develop products to diagnose and treat Age-related …See details»
Optherion, Inc. Completes $37 Million Start Up Financing
NEW HAVEN, Conn., Oct. 9 /PRNewswire/ -- Optherion, Inc., a company developing products to diagnose and treat dry and wet Age-related Macular Degeneration (AMD) and other chronic …See details»
$37 million raised for start up of Optherion Inc. - Ophthalmology …
Oct 25, 2007 New Haven, CT-Optherion, Inc has raised $37 million in start-up financing. The company is developing products to diagnose and treat dry and wet age-related macular …See details»
Optherion - Crunchbase
Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment ofSee details»
PRESS RELEASE: Optherion Completes $37 Million Start Up Financing
Oct 9, 2007 Optherion Completes $37 Million Start Up Financing NEW HAVEN, Conn., Oct. 9 -- Optherion, Inc., a company developing products to diagnose and treat dry and wet Age-related …See details»
Optherion - Pappas Capital
Optherion completes $37 million start up financing Optherion, Inc., a company developing products to diagnose and treat dry and wet Age-related Macular Degeneration (AMD) and …See details»
Regeneron Focuses on Age-Related Macular Degeneration - Cell …
Apr 21, 2008 Optherion is located in New Haven, CT, and at the University of Iowa. Instead of developing a systemic inflammation inhibitor, Optherion's approach will be to develop an …See details»
Optherion - Tech Stack, Apps, Patents & Trademarks
Nov 17, 2024 Optherion, Inc., a biotechnology company, develops diagnostic and disease-modifying therapeutics for the management and treatment ofSee details»
Emerging Drug Developer: Optherion | Fierce Biotech
The common wisdom in venture capital circles is that investment money flows fastest to the most mature products in the pipeline. Risk is out. Short-term gains--or what passes as short-term in …See details»
Optherion - Pappas Capital
Optherion's intellectual property was based on genetic discoveries linking certain genes to AMD and orphan renal diseases strongly influenced by components of the alternative complement …See details»
Opterion Health - Crunchbase Company Profile & Funding
Opterion Health is focused to bring innovation to dialysis care and foster home dialysis to improve the quality of life for patients.See details»